Chiral Technology: A Global Strategic Business Report
San Jose, California (PRWEB) April 04, 2012
Follow us on LinkedIn – The history of chiral technology dates back to mid-19th century, when chiral molecules were discovered, and since the 1950s numerous separation methods have been developed. Over the years, the application of chiral has spread across diverse areas ranging from hair sprays, clothes, drugs for treating diseases to several common materials. Despite recession halting the growth prospects of chiral technology to a certain extent, new developments in the field of chiral technology as well as demand for enantiopure compounds are expected to continue its contribution to the growth of the market in the post recessionary period.
A particularly important sector for chiral technology has been the pharmaceutical industry. Chiral technology plays a major role in the field of pharmaceuticals, with the industry gradually progressing towards enantiopure formulations. Currently a majority of newly introduced drugs are chiral and it is expected that nearly 95% of the pharmaceutical drugs would be chiral by 2020. Chiral drugs constitute the largest application of chiral technology. The single enantiomer form of a drug is therapeutically more effective and has fewer side effects. Regulatory agencies across the world have introduced guidelines and policies, which provide incentives for investment in single enantiomer drugs. The chiral drug industry constitutes approximately one-third of all drug sales worldwide. Pharmaceutical companies are using chirality as a tool to increase the span of their patented blockbuster drugs.
Another major market for chiral technology is in the field related to Agrochemicals. There exists huge potential for switching racemic pesticides to single enantiomers. Chiral technology also plays a vital role in other agrochemicals, such as fungicides, herbicides, and insecticides. Chiral actives are variants of existing actives that are produced to improve performance qualities and to remove harmful effects. Major groups of insecticides that include chiral compounds are carbamates, organochlorines, organophosphates, and pyrethroids.
Though a large number of chiral molecules that find their application in pharmaceutical, flavors, and agrochemicals industries are in pipeline, their development and commercialization is still moving at a snail’s pace. A key reason responsible for this is lack of general solutions to address issues related to chirality. In addition, development is mostly focused upon cost effectiveness, rather than on application and research of advanced, state-of-the-art technologies. However, technologies such as asymmetric hydrogenation are rapidly penetrating into the market. As chiral techniques develop over time, declining costs enable companies in accessing public-domain technologies that were hitherto outside their reach. Mounting pressure from end users such as the pharmaceuticals sector who are eager to realise cost efficiencies are forcing companies to provide know-how in all areas of production and manufacture of chiral material. Asymmetric synthesis, among the upcoming technologies, witnessed increased activity in terms of extensive academic and industrial investment. Industry biggies are keen on further growth in the market for chiral technologies as new process and reactions are discovered and applied in pharmaceutical synthesis. Furthermore, rising complexities of new chemical entities, desire to improve margins and evolution of advanced chiral technologies, are also driving the market.
Europe is the largest regional market for chiral technology enabling products, as stated by the new market research report on Chiral Technology. Chiral Intermediates represent the largest product segment in the global market for Chiral Technology. Chiral Analytical Products, with a CAGR of 5.21% over the analysis period, represent the fastest growing product segment in the global Chiral Technology market. Among end-uses, Pharmaceuticals occupies a lion’s share and are expected to show relatively faster growth compared to the end-uses.
Major players profiled in the report include Albemarle Corporation, BASF SE, Cambrex Corp., Chiral Quest Inc., Daicel Corporation, Chiral Technologies Worldwide, Chiral Technologies Inc., Chiral Technologies Europe, DSM Pharmaceutical Products, Regis Technologies Inc., Shasun Pharmaceuticals Limited, Sigma Aldrich Corp., among others.
The research report titled “Chiral Technology: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the chiral technology enabling products markets, impact of the global recession on the market, current trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants. The report provides annual sales estimates and projections for chiral technology enabling products market for the years 2009 through 2017 for the following geographic markets - US, Japan, Europe, and Rest of World, and by product segments – Chiral Intermediates, Chiral Analytical Products, and Others. Major end-use markets analyzed in the report include Pharmaceuticals and Agrochemicals. Also, a six-year (2003-2008) historic analysis is provided for additional perspective.
For more details about this comprehensive market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/